Evidence map›Paper›PMID 40708877›Full record

ReviewChemical science2025

Strategic molecular engineering of non-fused non-fullerene acceptors: efficiency advances and mechanistic insight.

Minmin Chen, Yong Zhang, Jinglin Liu, Qungui Wang, Peng Song, Yuanzuo Li

Abstract readReview
In one paragraph

Review in Chemical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Minmin ChenCollege of Science, Northeast Forestry University Harbin 150040 Heilongjiang China yzli@nefu.edu.cn liyuanzuo5203@126.com.
Yong ZhangSchool of Materials Science and Engineering, Harbin Institute of Technology Harbin 150001 Heilongjiang China yongzhang@hit.edu.cn.ORCID https://orcid.org/0000-0002-9587-4039
Jinglin LiuCollege of Science, Jiamusi University Jiamusi 154007 Heilongjiang China.
Qungui WangCollege of Physics, Sichuan University Chengdu 610065 P. R. China.
Peng SongDepartment of Physics, Liaoning University Shenyang 110036 Liaoning China.ORCID https://orcid.org/0000-0003-3093-0068
Yuanzuo LiCollege of Science, Northeast Forestry University Harbin 150040 Heilongjiang China yzli@nefu.edu.cn liyuanzuo5203@126.com.ORCID https://orcid.org/0000-0001-8530-6903

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-fullerene acceptor materials characterized by fused ring structures have garnered considerable attention due to their tunable molecular architectures, extensive and robust absorption spectra, and high photoelectric conversion efficiencies. Nonetheless, these materials present challenges, such as complex synthetic processes, elevated costs, and significant fabrication difficulties, which markedly impede their commercial viability. In light of these challenges, exploration of non-fused ring acceptors that are easier to synthesize and exhibit superior device characteristics has been proposed as a promising solution. Thus, the investigation of these structural acceptor materials is of substantial significance. This study reviews recent advances in non-fused ring acceptors for organic solar cells, guided by various engineering modulation strategies. The effects of molecular design approaches, including non-covalent conformation-locking engineering, core engineering, side-chain engineering, and substituent engineering, on device performance are examined. Finally, the mechanisms governing the behavior of non-fused-ring acceptor materials across different strategies are outlined, and future development trends and applications are anticipated.

Identifiers

PMID40708877
PMCPMC12285881

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.